Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
331 GBX | +3.28% | +1.22% | +50.45% |
May. 09 | Avon Protection wins UK MoD supply deal; Molten Ventures up | AN |
May. 09 | Molten Ventures wins UK MoD supply contract | AN |
Sales 2023 | 89.54M 114M | Sales 2024 * | 129M 165M | Capitalization | 331M 422M |
---|---|---|---|---|---|
Net income 2023 | -157M -200M | Net income 2024 * | -36M -45.87M | EV / Sales 2023 | 2.38 x |
Net cash position 2023 * | 49.23M 62.72M | Net cash position 2024 * | 18.3M 23.32M | EV / Sales 2024 * | 2.42 x |
P/E ratio 2023 |
-1.35
x | P/E ratio 2024 * |
-9.44
x | Employees | 714 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.81% |
Latest transcript on Oxford Biomedica plc
1 day | +3.28% | ||
1 week | +1.22% | ||
1 month | +15.33% | ||
3 months | +93.57% | ||
6 months | +97.02% | ||
Current year | +50.45% |
Managers | Title | Age | Since |
---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 62 | 23-03-26 |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 17-08-28 |
Chairman | 68 | 20-06-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leone Patterson
BRD | Director/Board Member | 61 | 23-04-30 |
Chairman | 68 | 20-06-23 | |
Stuart Henderson
BRD | Director/Board Member | 66 | 16-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 2 M€ | -.--% | ||
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 331 | +3.28% | 229,494 |
24-05-30 | 320.5 | +1.75% | 156,135 |
24-05-29 | 315 | -.--% | 117,382 |
24-05-28 | 315 | -3.67% | 107,653 |
24-05-24 | 327 | -2.24% | 124,216 |
Delayed Quote London S.E., May 31, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.45% | 421M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- OXB Stock